Application | Comment | Organism |
---|---|---|
medicine | the enzyme is important as a potential therapeutic target for the treatment of non small cell lung cancer | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
Q212L | site-directed mutagenesis,GTPase-deficient inactive mutant | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P30679 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
BEAS-2B cell | - |
Homo sapiens | - |
additional information | no enzyme expression in H-2122 , A-549, H-661, and H-1299 cancer cells, quantitaative enzyme expression analysis, overview | Homo sapiens | - |
NCI-H157 cell | - |
Homo sapiens | - |
non-small cell lung cancer cell | - |
Homo sapiens | - |
Subunits | Comment | Organism |
---|---|---|
heterotrimer | - |
Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
Galpha16 | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | G-protein, Galpha16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer, Wnt7a-stimulated ERK5 activation is Galpha16-dependent. Importance of Wnt7a signaling via its cognate receptor Frizzled9, a G-protein-coupled receptor, in inhibition of cell proliferation, anchorage-independent growth, and reversal of transformed phenotype in non small cell lung cancer primarily through activation of the tumor suppressor, PPARgamma. Galpha16 is a regulator of non small cell lung cancer cell proliferation and anchorage-independent cell growth. Galpha16 and Galphaq are important mediators of PPARgamma and E-cadherin expression in non small cell lung cancer cell lines | Homo sapiens |